|
|
||||||||
Ann Thorac Surg 2004;77:1774-1780
© 2004 The Society of Thoracic Surgeons
a Centre de Recherche, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Sainte-Foy, Québec, Canada
b Department of Radiology, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Sainte-Foy, Québec, Canada
Accepted for publication October 20, 2003.
* Address reprint requests to Dr Lacasse, Centre de Pneumologie, Hôpital Laval, 2725 Chemin Ste-Foy, Sainte-Foy, Quebec G1V 4G5, Canada
e-mail: yves.lacasse{at}med.ulaval.ca
| Abstract |
|---|
|
|
|---|
METHODS: This study involved, in a blind comparison of VB and FB, consecutive patients presenting with symptoms or plain chest radiography abnormalities raising the suspicion of pulmonary neoplasm. After the standard chest computed tomography (CT), additional helical CT data were acquired from the aortic arch to the origin of the segmental bronchi of the inferior lobes in one 20-second breath hold using an helicoidal CT scan (3.0-mm collimation with a pitch of 1.5 and 1.5-mm reconstruction intervals).
RESULTS: One hundred ninety patients were enrolled; 136 patients (including 63 with an endobronchial lesion at FB) contributed to the primary analysis. The sensitivity and specificity of VB to detect endobronchial lesions were 68% (95% confidence interval [CI]: 55% to 79%) and 90% (95% CI: 81% to 96%), respectively. Overall, the agreement between VB and FB regarding the location on endobronchial lesions was substantial (weighted kappa: 0.66). However, VB detected only 26 of the 34 lobar lesions (sensitivity: 76%; CI: 59% to 89%) and 11 of the 23 segmental lesions (sensitivity: 48%; CI: 27% to 69%).
CONCLUSIONS: Beyond the mainstem bronchi, VB is not accurate enough to detect endobronchial lesions and to obviate FB in patients presenting with a suspicion of malignancy.
| Introduction |
|---|
|
|
|---|
Recently, technologic advances in medical imaging permitted the introduction of tridimensional exploration of the bronchial tree [10]. The images obtained through volumetric (helical or spiral) chest computed tomography (CT) can be used to reconstruct in three dimensions the bronchial tree. Virtual bronchoscopy (VB) allows the navigation in the airways and the exact location of endobronchial lesions in relation to extrabronchial structures [11]. Virtual bronchoscopy has the potential to identify those patients with an endobronchial lesion that is accessible to FB [12]. We hypothesized that VB could obviate flexible bronchoscopy (FB) if no endobronchial lesion is detected in patients presenting with a suspicion of malignancy [13]. The objective of this study was to evaluate the accuracy (in terms of sensitivity and specificity) of virtual bronchoscopy in the detection of endobronchial lesion. Secondarily, we sought to determine the anatomical limit of detection of endobronchial lesions by VB.
| Patients and methods |
|---|
|
|
|---|
Virtual bronchoscopy
The images needed to reconstruct VB were acquired at the same time as the chest CT scan ordered for the usual investigation of the suspected pulmonary lesion. Because the infusion of medium contrast material creates artifacts [14], the standard contrast CT was first done by using a single-detector helical CT scanner (GE LightSpeed, Milwaukee, WI) with the following protocol: 7.0-mm collimation, 1.7 pitch, 120 kV, 240 mA, 0.8 second tube rotation. Then, within 5 minutes to allow the dilution of the contrast medium into the circulation, additional helical CT data for VB were obtained from the aortic arch to the origin of the segmental bronchi of the inferior lobes in one 20-second breath hold. Scans consisted of 3.0-mm roentgenogram beam collimation (slice thickness) with a pitch of 1.5 and 1.5-mm reconstruction intervals. Endoscopic views were obtained with the Navigator software (GE Medical Systems, Milwaukee, WI). All data were recorded on optical disks. Radiation exposure was estimated to be about 25% to 50% more than with a conventional thoracic CT scan.
All images were interpreted on the computer station by a pair of pulmonologists who performed the bronchoscopies (Y.L. and B.R., Y.L. and S.M., or B.R. and S.M.). Consensus was reached on site. The readers were masked to the patients' history and to results of FB and final diagnosis. However, the corresponding axial CT slices and multiplanar reconstructions were available at the time of the VB asessment. We used the scheme of interpretation described by Finkelstein and associates [15] for data analysis: the presence and location of an obstructive lesion (defined as bronchial narrowing of > 50%) or endoluminal mass (defined as a mass protruding into the lumen with
50% occlusion) or mucosal abnormalities were noted. In addition, we noted the quality of each VB: it was deemed of good quality when it allowed the inspection of all segmental bronchi at the location of a lesion seen on the axial slices in addition to all lobar bronchi without artifacts; otherwise, the VB was deemed of bad quality.
Reference standard: flexible bronchoscopy
Flexible bronchoscopy was considered the reference test from which we determined the presence or absence of endobronchial lesion when describing division of the patients into cases and controls, respectively. The technique was performed by the attending pulmonologist using Olympus BF-P200 bronchoscopes under electrocardiographic and pulse oxygen saturation monitoring and, in some cases, under light sedation according to the treating physician's prescription. Local anesthesia was first given at the level of the superior airways (nose and throat). The bronchial tree was explored systematically (trachea, mainstem bronchi, lobar and segmental bronchi) before any biopsy was performed to avoid any endobronchial bleeding making the remaining of the exploration difficult. The flexible bronchoscopies were all recorded on videotape for subsequent reassessment by a second pulmonologist who was not aware of the clinical characteristics of the patient. Any disagreement between the two pulmonologists was resolved by consensus. The pulmonologists involved in the FB interpretation were different from those involved in the VB interpretation. We also used the scheme of interpretation described by Finkelstein and associates [15] for data analysis: the presence and location of an obstructive lesion, endoluminal mass (defined above), or mucosal lesions (hemorrhage, erythema, or tissue friability) were recorded. The order in which both procedures were performed was not protocol-based and did not matter. We noted the length of time between VB and FB.
Statistical analysis
Descriptive statistics
Descriptive statistics (proportions, median and interquartile range, or mean, standard deviations [SD] and associated 95% confidence intervals [95% CI] when appropriate) were used to describe the study population.
Sensitivity and specificity
Our cohort of patients represented a wide spectrum of diseases and divided by itself in two groups according to the presence (cases) or the absence (controls) of endobronchial lesions [16]. The VB results were compared with those of FB, whatever the location of the lesion. For instance, a lesion localized in the middle lobe bronchi at the virtual bronchoscopy could be actually located in the right upper lobe bronchi. In such a circumstance, the VB was considered as a "true positive" since it will have identified a patient for whom FB is indicated. We computed the sensitivity (the proportion of patients with an endobronchial lesion at FB in whom VB was positive), specificity (the proportion of patients with no endobronchial lesion at FB in whom VB was negative), positive predictive value (the proportion of patients with an endobronchial lesion at VB in whom FB was positive) and negative predictive value (the proportion of patients with no endobronchial lesion at VB in whom FB was negative) of VB and associated 95% CI.
Uninterpretable virtual bronchoscopies
In addition, in order to take into account the uninterpretable VB (ie, VB that failed to meet the minimum standards specified for their performance), we conducted a secondary analysis according to the method described by Simel and associates [17]. In this analysis, the positive yield of VB is the probability of a positive or negative result when disease is present. The negative yield of VB is the probability of a positive or a negative result when disease is absent. We then computed the "worst case sensitivity" (ie, the sensitivity obtained when uninterpretable results are combined with negative results) and the "worst case specificity" (ie, the specificity obtained when uninterpretable results are combnined with positive results) as follows: worst case sensitivity = sensitivity x positive yield; worst case specificity = specificity x negative yield.
Anatomical limit of detection
We determined the concordance between the location of the lesion detected at VB and the actual location of the lesions detected at FB as follows. Each lesion was classified according to its location both at VB and FB (trachea, mainstem, lobar, or segmental bronchi). The agreement between VB and FB was calculated using the weighted kappa statistic. We qualified a priori the magnitude of the agreement as follows: a kappa ranging from 0 to 0.20 would denote a slight agreement; 0.21 to 0.40, a fair agreement; 0.41 to 0.60, a moderate agreement, and larger than 0.60, a substantial agreement [18]. We also computed the sensitivity of VB for each of anatomical level.
Sample size
We determined the sample size needed according to the desired precision of the expected values of sensitivity [19]. Since the main objective of this study was to identify the patients who would really benefit from flexible bronchoscopy, we assumed that all the endobronchial lesions should be detected. We therefore calculated that 60 patients with an endobronchial lesion should be studied if the lower bound of the 95% CI around the sensitivity estimate is to exclude 95%. Before our study, we conducted a retrospective chart review that indicated that, during the preceding year, 1 patient out of 3 submitted to both FB and chest CT scan for the initial investigation of symptoms or plain chest radiography abnormalities raising the suspicion of pulmonary neoplasm was actually found to have an endobronchial lesion at FB. Accordingly, 180 patients were needed to complete this study.
| Results |
|---|
|
|
|---|
|
|
|
|
|
Anatomical limit of detection of VB
Overall, the agreement between VB and FB regarding the location on endobronchial lesions was substantial (weighted kappa: 0.66; 95% CI: 0.49 to 0.82; Table 5).
Virtual bronchoscopy detected all 6 lesions located either in trachea or in a main stem bronchi. However, VB detected only 26 of the 34 lobar lesions (sensitivity: 76%; CI: 59% to 89%) and 11 of the 23 segmental lesions (sensitivity: 48%; CI: 27% to 69%). Typical examples of correlations between VB and FB images are presented in Figure 2.
|
|
| Comment |
|---|
|
|
|---|
Our study was preceded by a number of enthusiastic reports of the accuracy of VB in detecting endoluminal lesions [13, 15, 2027]. All reported on small cohorts of patients most often selected on the basis of a known endoluminal lesion (Table 6). The latest published was by Finkelstein and collaborators [15]. Their study differed from ours in that 1.25-mm section intervals were obtained from a multidetector helical CT scanner. Twenty patients with thoracic malignant disease contributed to the analysis, including 7 with no lesion at FB. All 7 had normal VB (specificity: 100%). The authors reported that VB detected 18 of 22 abnormal FB findings (all 13 obstructive lesions, 5 of 6 endoluminal lesions, and none of 3 mucosal lesions). When analyzed on a per-lesion basis, the sensitivity of VB was 82%. The authors did not provide any data on the location of the lesions at VB and any confidence intervals around their estimate of sensitivity and specificity. We computed them and obtained a 95% CI around the sensitivity of 60% to 95%, and a 95% CI around the specificity of 59% to 100%. When analyzed on a per-patient basis (as we did), VB detected an endobronchial lesion in 11 of their 13 patients who had one (sensitivity: 85%; 95% CI: 55% to 98%). These wide confidence intervals indicate much uncertainty around the estimates.
|
It is likely that the forthcoming multidetector helical CT scanners will improve the accuracy of VB to detect endobronchial lesions. Nevertheless, an obvious limitation of VB is that, whatever the quality of the images obtained, it will never enable acquisition of tissue material for cytologic or histologic analysis. Our data demonstrated that even when no endobronchial lesion is seen at FB in patients ultimately diagnosed with thoracic malignancy, FB provides a diagnosis in 36% (data not shown). Another limitation of VB over FB is that it is not as sensitive as actual endoscopy in detecting the cause of dynamic airway obstruction [23].
Is VB a diagnostic tool or a medical toy? The same question was asked 25 years ago about FB which has now become a routine procedure [1]. We conclude that VB is not accurate enough to detect endobronchial lesions and to obviate FB in patients presenting with a suspicion of malignancy. On the other hand, we submit that VB may be useful in a variety of clinical circumstances and may supplement FB in many situations. Virtual bronchoscopy visualizes areas beyond even high-grades stenoses. It may guide bronchoscopic biopsies, surgical interventions and palliative therapy (such as laser or photodynamic techniques) [13, 15]. It may represent an objective method for sequentially evaluating endobronchial abnormalities and assess treatment responses [15]. It may be helpful for postoperative follow-up examinations, such as after stent implantation [26, 28], or to design custom-made tracheotomy cannula [29]. It has been suggested as a method of detection of bronchial anastomotic complication in lung transplant recipients [30]. Virtual bronchoscopy may also be used for endoscopy training. These potential indications await further clinical assessment.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Y. Dolina, D. C. Cornish, S. A. Merritt, L. Rai, R. Mahraj, W. E. Higgins, and R. Bascom Interbronchoscopist Variability in Endobronchial Path Selection: A Simulation Study Chest, April 1, 2008; 133(4): 897 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Horton, M. R. Horton, and E. K. Fishman Advanced Visualization of Airways with 64-MDCT: 3D Mapping and Virtual Bronchoscopy Am. J. Roentgenol., December 1, 2007; 189(6): 1387 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Heyer, T. Kagel, S. P. Lemburg, J. W. Walter, J. de Zeeuw, K. Junker, K.-M. Mueller, V. Nicolas, and T. T. Bauer Transbronchial Biopsy Guided by Low-Dose MDCT: A New Approach for Assessment of Solitary Pulmonary Nodules Am. J. Roentgenol., October 1, 2006; 187(4): 933 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Shitrit, P. Valdsislav, A. Grubstein, D. Bendayan, M. Cohen, and M. R. Kramer Accuracy of Virtual Bronchoscopy for Grading Tracheobronchial Stenosis: Correlation With Pulmonary Function Test and Fiberoptic Bronchoscopy Chest, November 1, 2005; 128(5): 3545 - 3550. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Asahina, K. Yamazaki, Y. Onodera, E. Kikuchi, N. Shinagawa, F. Asano, and M. Nishimura Transbronchial Biopsy Using Endobronchial Ultrasonography With a Guide Sheath and Virtual Bronchoscopic Navigation Chest, September 1, 2005; 128(3): 1761 - 1765. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |